2-year follow-up of a sham-controlled trial of minimally invasive sacroiliac joint fusion (63 patients): pain fell 3.1 points from baseline after initial fusion and 3.5 after crossover to fusion; 6-month primary difference versus sham was non-significant (−1.0, p=0.13).
RCTn = 63
Kibsgård et al. Minimally Invasive Sacroiliac Joint Fusion Compared with Sham Operation (SIFSO Trial): A Concise Follow-up, at 2 Years, of a Previous Report